Roger Kitterman

Managing Partner at Mass General Brigham Ventures

Brookline, Massachusetts

Overview

Roger Kitterman is the Managing Partner at Mass General Brigham Ventures, with significant experience in venture capital, business development, and licensing within the biotech sector. He has held senior roles at Mass General Brigham and founded Mass Medical Angels, demonstrating a strong track record of leadership and strategic investment in innovative healthcare companies.

Work Experience

Mass General Brigham

Senior Vice President, Venture, Business Development and Licensing
2016 - Current

Mass General Brigham specializes in providing medical treatments and health diagnostics services.

massgeneralbrigham.org

Mass General Brigham Ventures

Managing Partner
2007
Mass General Brigham Ventures is a seed and early-stage venture capital firm founded in 2008 to advance new science and technology based on discovery and invention originating in the Mass General Brigham system. The fund invests in medical innovations created by MGB's world-class research hospitals, including Massachusetts General Hospital and Brigham and Women’s Hospital, two of the principal teaching hospitals of the Harvard Medical School. We invest in leading-edge life science technologies with the goal of bringing discoveries, inventions and innovations to the market benefit of patients worldwide.

Affinia Therapeutics

Board representative
2020

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

Raised $170,000,000.00 from Woodline Partners, TCG Crossover, Octagon Capital Advisors, Atlas Venture, Farallon Capital Management, Casdin Capital, Perceptive Advisors, Lonza, Google Ventures and F-Prime Capital.

affiniatx.com